For: | Norton SE, Ward-Hartstonge KA, Taylor ES, Kemp RA. Immune cell interplay in colorectal cancer prognosis. World J Gastrointest Oncol 2015; 7(10): 221-232 [PMID: 26483876 DOI: 10.4251/wjgo.v7.i10.221] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v7/i10/221.htm |
Number | Citing Articles |
1 |
Maya Vladova Gulubova, Dimitur Chavdarov Chonov, Koni Vancho Ivanova, Mariyna Kostova Hristova, Maria Magdalena Krasimirova-Ignatova, Tatyana Ivanova Vlaykova. Intratumoural expression of IL-6/STAT3, IL-17 and FOXP3 immune cells in the immunosuppressive tumour microenvironment of colorectal cancerImmune cells-positive for IL-6, STAT3, IL-17 and FOXP3 and colorectal cancer development. Biotechnology & Biotechnological Equipment 2022; 36(1): 327 doi: 10.1080/13102818.2022.2072765
|
2 |
Marwan Fakih, Ching Ouyang, Chongkai Wang, Travis Yiwey Tu, Maricel C. Gozo, May Cho, Marvin Sy, Jeffrey A. Longmate, Peter P. Lee. Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome. Journal of Clinical Investigation 2019; 129(10): 4464 doi: 10.1172/JCI127046
|
3 |
J. K. H. Leman, L. Munoz-Erazo, R. A. Kemp. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1226: 1 doi: 10.1007/978-3-030-36214-0_1
|
4 |
Roberta De Matteis, Magdalena B. Flak, Maria Gonzalez-Nunez, Shani Austin-Williams, Francesco Palmas, Romain A. Colas, Jesmond Dalli. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Science Advances 2022; 8(5) doi: 10.1126/sciadv.abl5420
|
5 |
Atsushi Sugimoto, Tatsunari Fukuoka, Masatsune Shibutani, Hiroaki Kasashima, Kishu Kitayama, Masaichi Ohira, Kiyoshi Maeda. Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02722-6
|
6 |
Salman M. Toor, Rowaida Z. Taha, Varun Sasidharan Nair, Reem Saleh, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer. Cancer Immunology, Immunotherapy 2021; 70(3): 803 doi: 10.1007/s00262-020-02727-0
|
7 |
Theodoros Argyropoulos, Periklis G. Foukas, Effrosyni Karakitsou, Stefanos Konstantoudakis, Maria Kefala, Nektarios Koufopoulos, Nikolaos Machairas, Ioannis Panayiotides, Konstantinos Triantafyllou. Predictive Value of CD3, CD8, CD45RO Expression in Stage II/III Colorectal Cancer. International Journal of Reliable and Quality E-Healthcare 2018; 7(3): 18 doi: 10.4018/IJRQEH.2018070102
|
8 |
Pâmela Portela, Joice Merzoni, Juliana D. Lindenau, Daniel C. Damin, Timothy John Wilson, Rafael Roesler, Gilberto Schwartsmann, Luiz Fernando Jobim, Mariana Jobim. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer. Human Immunology 2017; 78(3): 263 doi: 10.1016/j.humimm.2017.01.003
|
9 |
Yidi Qu, Hongxin Yang, Siyu Li, Lanzhou Li, Yu Li, Di Wang. The involvement of Th1 cell differentiation in the anti-tumor effect of purified polysaccharide from Sanghuangporus vaninii in colorectal cancer via multi-omics analysis. International Journal of Biological Macromolecules 2023; 237: 123927 doi: 10.1016/j.ijbiomac.2023.123927
|
10 |
Dwaipayan Chakraborty, Subhadip Pati, Sayantan Bose, Subhanki Dhar, Saikat Dutta, Gaurisankar Sa. Cancer immunotherapy: present scenarios and the future of immunotherapy. The Nucleus 2019; 62(2): 143 doi: 10.1007/s13237-019-00273-4
|
11 |
Srustidhar Das, Cristian Doñas, Paulina Akeus, Marianne Quiding-Järbrink, J. Rodrigo Mora, Eduardo J. Villablanca, Xiang Xue. β7 integrins contribute to intestinal tumor growth in mice. PLOS ONE 2018; 13(9): e0204181 doi: 10.1371/journal.pone.0204181
|
12 |
Chiara Porta, Alessandro Ippolito, Francesca Maria Consonni, Lorenzo Carraro, Giuseppe Celesti, Carmen Correale, Fabio Grizzi, Fabio Pasqualini, Silvia Tartari, Maurizio Rinaldi, Paolo Bianchi, Fiorella Balzac, Stefania Vetrano, Emilia Turco, Emilio Hirsch, Luigi Laghi, Antonio Sica. Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression. Cancer Immunology Research 2018; 6(5): 578 doi: 10.1158/2326-6066.CIR-17-0036
|
13 |
Julia KH Leman, Sarah K Sandford, Janet L Rhodes, Roslyn A Kemp. Multiparametric analysis of colorectal cancer immune responses. World Journal of Gastroenterology 2018; 24(27): 2995-3005 doi: 10.3748/wjg.v24.i27.2995
|
14 |
Elizabeth A. Comen, Robert L. Bowman, Maria Kleppe. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. Frontiers in Cell and Developmental Biology 2018; 6 doi: 10.3389/fcell.2018.00056
|
15 |
Bert H. O’Neil, John M. Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A. Piha-Paul, Mark N. Stein, Albiruni R. Abdul Razak, Katia Dotti, Armando Santoro, Roger B. Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han, Gregory Lesinski. Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. PLOS ONE 2017; 12(12): e0189848 doi: 10.1371/journal.pone.0189848
|
16 |
Maria E. Reyes, Marjorie de La Fuente, Marcela Hermoso, Carmen G. Ili, Priscilla Brebi. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00901
|
17 |
Jennifer K. Colby, Jonathan Jaoude, Fuyao Liu, Imad Shureiqi. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer and Metastasis Reviews 2018; 37(2-3): 289 doi: 10.1007/s10555-018-9743-z
|
18 |
Virginia Niemi, Douglas Gaskarth, Roslyn A. Kemp. Extensive variability in the composition of immune infiltrate in different mouse models of cancer. Laboratory Animal Research 2020; 36(1) doi: 10.1186/s42826-020-00075-9
|
19 |
Su-Man Kim, Eun-Mi Kim, Kon-Young Ji, Hwa-Youn Lee, Su-Min Yee, Su-Min Woo, Ja-Woon Yi, Chul-Ho Yun, Harim Choi, Hyung-Sik Kang. TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/β-catenin and Erk Signaling. Cancers 2019; 11(9): 1315 doi: 10.3390/cancers11091315
|
20 |
Kirsten A Ward‐Hartstonge, Roslyn A Kemp. Regulatory T‐cell heterogeneity and the cancer immune response. Clinical & Translational Immunology 2017; 6(9) doi: 10.1038/cti.2017.43
|
21 |
Tomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, Hirokazu Okayama, Eisei Endo, Katsuharu Saito, Wataru Sakamoto, Shotaro Fujita, Hisahito Endo, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Shinji Ohki, Kazunori Shimada, Kiyoshi Yoshimura, Takuya Tsunoda, Koji Kono. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers. Cancer Immunology, Immunotherapy 2020; 69(1): 23 doi: 10.1007/s00262-019-02433-6
|
22 |
Wenhao Weng, Ajay Goel. Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Seminars in Cancer Biology 2022; 80: 73 doi: 10.1016/j.semcancer.2020.02.011
|
23 |
Dounia Chraa, Asmaa Naim, Daniel Olive, Abdallah Badou. T lymphocyte subsets in cancer immunity: Friends or foes. Journal of Leukocyte Biology 2019; 105(2): 243 doi: 10.1002/JLB.MR0318-097R
|
24 |
Ming Cai, Ke Zhao, Lin Wu, Yanqi Huang, Minning Zhao, Qingru Hu, Qicong Chen, Su Yao, Zhenhui Li, Xinjuan Fan, Zaiyi Liu. Artificial intelligence-based analysis of tumor-infiltrating lymphocyte spatial distribution for colorectal cancer prognosis. Chinese Medical Journal 2024; 137(4): 421 doi: 10.1097/CM9.0000000000002964
|
25 |
Hui Wang, Tian Tian, Jinhua Zhang. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. International Journal of Molecular Sciences 2021; 22(16): 8470 doi: 10.3390/ijms22168470
|